Literature DB >> 15581849

On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids.

Sébastien Deshayes1, Sabine Gerbal-Chaloin, May C Morris, Gudrun Aldrian-Herrada, Pierre Charnet, Gilles Divita, Frédéric Heitz.   

Abstract

Recently, we described a new strategy for the delivery of nucleic acids into mammalian cells, based on an amphipathic peptide of 27 residues called MPG, which was designed on the basis of a hydrophobic domain derived from a fusion sequence associated with a nuclear localization sequence and separated by a linker. This peptide carrier constitutes a powerful tool for the delivery of nucleic acids in cultured cells, without requiring any covalent coupling. We have examined the conformational states of MPG in its free form and complexed with a cargo, as well as its ability to interact with phospholipids, and have investigated the structural consequences of these interactions. In spite of its similarity to the similarly designed cell-penetrating peptide Pep-1, MPG behaves significantly differently from the conformational point of view. Circular dichroism (CD) analysis reveals a transition from a nonstructured to a beta-sheet conformation upon interaction with phospholipids. We propose that the membrane crossing process involves formation of a transient transmembrane pore-like structure. Partial conformational change of MPG is associated with formation of a complex with its cargo, and an increase in sheet content occurs upon association with the cell membrane.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581849     DOI: 10.1016/j.bbamem.2004.09.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

Review 1.  Silk-based delivery systems of bioactive molecules.

Authors:  Keiji Numata; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2010-03-16       Impact factor: 15.470

Review 2.  Cell-penetrating peptides and antimicrobial peptides: how different are they?

Authors:  Sónia Troeira Henriques; Manuel Nuno Melo; Miguel A R B Castanho
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

Review 3.  Functional peptides for siRNA delivery.

Authors:  Wanyi Tai; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2016-08-13       Impact factor: 15.470

Review 4.  A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin.

Authors:  Kirk K Hou; Hua Pan; Paul H Schlesinger; Samuel A Wickline
Journal:  Biotechnol Adv       Date:  2015-05-27       Impact factor: 14.227

Review 5.  Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.

Authors:  Helerin Margus; Kärt Padari; Margus Pooga
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

6.  Melittin derived peptides for nanoparticle based siRNA transfection.

Authors:  Kirk K Hou; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

7.  Aromatic D-amino acids act as chemoattractant factors for human leukocytes through a G protein-coupled receptor, GPR109B.

Authors:  Yoko Irukayama-Tomobe; Hirokazu Tanaka; Takehiko Yokomizo; Tomomi Hashidate-Yoshida; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 8.  Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells.

Authors:  Xuguang Chen; Alireza Nomani; Niket Patel; Faranak S Nouri; Arash Hatefi
Journal:  Biomaterials       Date:  2017-10-20       Impact factor: 12.479

9.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.